SureTrader
Home > Boards > US Listed > Medical - Healthcare > Sanofi-Aventis (sny)

A bump on the road but still going!

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Trend-Setter Member Profile
 
Followed By 3
Posts 467
Boards Moderated 0
Alias Born 07/19/13
160x600 placeholder
Sanofi CFO Jerome Contamine to Depart Later This Year Dow Jones News - 4/18/2018 2:58:00 AM
Sanofi in Talks With Advent International to Sell Zentiva for EUR1.92 Billion Dow Jones News - 4/17/2018 3:16:00 AM
Sanofi va investir 350 millions d'euros dans une unité de production de vaccins au Canada PR Newswire (Canada) - 4/12/2018 5:28:00 PM
Sanofi to invest €350 million in Canadian vaccine facility PR Newswire (Canada) - 4/12/2018 5:20:00 PM
New tools, support and information on insulin use now available to Canadians living with Type 2 diabetes aiming to maintain h... PR Newswire (Canada) - 4/12/2018 8:00:00 AM
Sanofi to Invest EUR350 Million in Canadian Vaccine Facility Dow Jones News - 4/12/2018 1:44:00 AM
New Sanofi insulin savings program aims to lower out-of-pocket costs for people living with diabetes PR Newswire (US) - 4/5/2018 8:03:00 AM
FDA approves Toujeo® Max SoloStar® PR Newswire (US) - 3/27/2018 8:03:00 AM
Praluent® (alirocumab) a significativement réduit le risque d'événements cardiovasculaires chez des patients à risque é... PR Newswire (Canada) - 3/10/2018 7:20:00 PM
Praluent® (alirocumab) significantly reduced risk of cardiovascular events in high-risk patients, and was associated with lo... PR Newswire (Canada) - 3/10/2018 7:18:00 PM
Regeneron and Sanofi Plan to Cut Cholesterol Drug Price in Exchange for Wider Coverage Dow Jones News - 3/10/2018 6:15:00 PM
Regeneron and Sanofi Plan to Cut Cholesterol Drug Price in Exchange for Wider Coverage Dow Jones News - 3/10/2018 9:29:00 AM
Sanofi and Regeneron announce plans to make Praluent® more accessible and affordable for patients with the greatest health r... PR Newswire (US) - 3/10/2018 9:02:00 AM
Praluent® (alirocumab) Injection significantly reduced risk of cardiovascular events in high-risk patients, and was associat... PR Newswire (US) - 3/10/2018 9:00:00 AM
Sanofi in Exclusive Talks with Evotec to Create R&D Platform Dow Jones News - 3/8/2018 2:52:00 AM
Torrent Pharma Prepares EUR2 Billion Bid for Sanofi's Zentiva -Mint Dow Jones News - 3/7/2018 3:36:00 AM
Sanofi Proposes Reappointment of CEO Olivier Brandicourt to Board Dow Jones News - 3/6/2018 10:57:00 AM
Major Cannabis Producer Canopy Bids for Spain's Alcaliber -Bloomberg Dow Jones News - 3/6/2018 9:23:00 AM
Sanofi Receives Antitrust Clearances in U.S., Germany for Ablynx Acquisition Dow Jones News - 3/1/2018 5:19:00 AM
Sanofi Says U.S. Waiting Period for Bioverativ Has Expired Dow Jones News - 2/23/2018 6:44:00 AM
Stronger European Earnings Augur More M&A, Higher Dividends Dow Jones News - 2/19/2018 6:54:00 AM
Results from Innovative Phase 2 Tuberculosis Vaccine Trial Offer Potential for New BCG Revaccination Strategies, Hope For Sub... PR Newswire (US) - 2/19/2018 6:00:00 AM
Correction to Sanofi Dengue Vaccine Article on Feb. 2 Dow Jones News - 2/15/2018 12:00:00 PM
Sanofi and SK Chemicals Sign Licensing Agreement for Flu Vaccine Technology Dow Jones News - 2/12/2018 12:36:00 PM
Premier traitement ciblé pour les adultes atteints de dermatite atopique modérée à sévère, Dupixent(MC) maintenant offe... PR Newswire (Canada) - 2/8/2018 7:00:00 AM
Trend-Setter   Wednesday, 01/03/18 04:27:02 PM
Re: Trend-Setter post# 79
Post # of 85 
A bump on the road but still going!

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist